Royal Papworth Hospital NHS Foundation Trust

Association


Location: Cambridge, United Kingdom (GB) GB

ISNI: 0000000403835994

ROR: https://ror.org/01qbebb31

Show on Map:

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Outcomes of 10,312 patients treated with everolimus-eluting bioresorbable scaffolds during daily clinical practice – results from the European Absorb Consortium (2021) Wiebe J, Hofmann FJ, West N, Baumbach A, Carrie D, Bermudez EP, Cayla G, et al. Journal article Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE- ABSORB randomised clinical trial (2020) Smits PC, Chang CC, Chevalier B, West NEJ, Gori T, Barbato E, Tarantini G, et al. Journal article ABSORB bioresorbable scaffold versus Xience metallic stent in acute coronary syndromes with treated with percutaneous coronary intervention. A subanalysis of the COMPARE-ABSORB trial (2019) Van Geuns RJ, Smits PC, Chang CC, Wlodarczyk A, Chevalier B, West N, Gori T, et al. Conference contribution Optimal Vessel Sizing for the Bioresorbable Scaffold Implantation and the Incidence of Scaffold Thrombosis: Insights From the COMPARE-ABSORB Trial (2019) Chang CC, Onuma Y, Chevalier B, West N, Gori T, Barbato E, Tarantini G, et al. Conference contribution Absorb bioresorbable scaffold versus Xience metallic stent for prevention of restenosis following percutaneous coronary intervention in patients at high risk of restenosis: Rationale and design of the COMPARE ABSORB trial (2019) Chang CC, Onuma Y, Achenbach S, Barbato E, Chevalier B, Cook S, Dudek D, et al. Journal article Interplay of cell–cell contacts and RhoA/MRTF-A signaling regulates cardiomyocyte identity (2018) Dorn T, Kornherr J, Parrotta EI, Zawada D, Ayetey H, Santamaria G, Iop L, et al. Journal article